| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print April 26, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From (OSI) Eyetech, Incorporated, Lexington, Massachusetts
Vascular endothelial growth factor-A (VEGF-A) has recently been recognized as an important neuroprotectant in the central nervous system. Given its position as an anti-angiogenic target in the treatment of human diseases, understanding the extent of VEGF’s role in neural cell survival is paramount. Here, we used a model of ischemia-reperfusion injury and found that VEGF-A exposure resulted in a dose-dependent reduction in retinal neuron apoptosis. Although mechanistic studies suggested that VEGF-A-induced volumetric blood flow to the retina may be partially responsible for the neuroprotection, ex vivo retinal culture demonstrated a direct neuroprotective effect for VEGF-A. VEGF receptor-2 (VEGFR2) expression was detected in several neuronal cell layers of the retina, and functional analyses showed that VEGFR2 was involved in retinal neuroprotection. VEGF-A was also shown to be involved in the adaptive response to retinal ischemia. Ischemic preconditioning 24 hours before ischemia-reperfusion injury increased VEGF-A levels and substantially decreased the number of apoptotic retinal cells. The protective effect of ischemic preconditioning was reversed after VEGF-A inhibition. Finally, chronic inhibition of VEGF-A function in normal adult animals led to a significant loss of retinal ganglion cells yet had no observable effect on several vascular parameters. These findings have implications for both neural pathologies and ocular vascular diseases, such as diabetic retinopathy and age-related macular degeneration.
This article has been cited by other articles:
 |
|
 |
|
  D. M. Albert, A. Neekhra, S. Wang, S. R. Darjatmoko, C. M. Sorenson, R. R. Dubielzig, and N. Sheibani Development of Choroidal Neovascularization in Rats With Advanced Intense Cyclic Light-Induced Retinal Degeneration Arch Ophthalmol, February 1, 2010; 128(2): 212 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jiang, R. J. Walker, and J. J. Steinle Age-Associated Increase in Cleaved Caspase 3 Despite Phosphorylation of IGF-1 Receptor in the Rat Retina J Gerontol A Biol Sci Med Sci, November 1, 2009; 64A(11): 1154 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. McFee, R. A. Artac, R. M. McFee, D. T. Clopton, R. A. L. Smith, T. G. Rozell, and A. S. Cupp Inhibition of Vascular Endothelial Growth Factor Receptor Signal Transduction Blocks Follicle Progression but Does Not Necessarily Disrupt Vascular Development in Perinatal Rat Ovaries Biol Reprod, November 1, 2009; 81(5): 966 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Horng, G. Kreiman, C. Ellsworth, D. Page, M. Blank, K. Millen, and M. Sur Differential Gene Expression in the Developing Lateral Geniculate Nucleus and Medial Geniculate Nucleus Reveals Novel Roles for Zic4 and Foxp2 in Visual and Auditory Pathway Development J. Neurosci., October 28, 2009; 29(43): 13672 - 13683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bartoli, M. Al-Shabrawey, M. Labazi, M. A. Behzadian, M. Istanboli, A. B. El-Remessy, R. W. Caldwell, D. M. Marcus, and R. B. Caldwell HMG-CoA Reductase Inhibitors (Statin) Prevents Retinal Neovascularization in a Model of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2009; 50(10): 4934 - 4940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C Caires, J. de Avila, and D. J McLean Vascular endothelial growth factor regulates germ cell survival during establishment of spermatogenesis in the bovine testis Reproduction, October 1, 2009; 138(4): 667 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Avci, R. Avci, U. U. Inan, and B. Kaderli Comparative Evaluation of Apoptotic Activity in Photoreceptor Cells after Intravitreal Injection of Bevacizumab and Pegaptanib Sodium in Rabbits Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3438 - 3446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bock, J. Onderka, C. Rummelt, T. Dietrich, B. Bachmann, F. E. Kruse, U. Schlotzer-Schrehardt, and C. Cursiefen Safety Profile of Topical VEGF Neutralization at the Cornea Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2095 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet Role and Therapeutic Potential of VEGF in the Nervous System Physiol Rev, April 1, 2009; 89(2): 607 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Wroblewski, J. A. Wells III, A. P. Adamis, R. R. Buggage, E. T. Cunningham Jr, M. Goldbaum, D. R. Guyer, B. Katz, M. M. Altaweel, and for the Pegaptanib in Central Retinal Vein Occlusi Pegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion Arch Ophthalmol, April 1, 2009; 127(4): 374 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Quigley Can Diabetes Be Good for Glaucoma? Why Can't We Believe Our Own Eyes (or Data)? Arch Ophthalmol, February 1, 2009; 127(2): 227 - 229. [Full Text] [PDF]
|
|
|
|
|
|
M. Saint-Geniez, T. Kurihara, and P. A. D'Amore Role of Cell and Matrix-Bound VEGF Isoforms in Lens Development Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 311 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L J Singerman, H Masonson, M Patel, A P Adamis, R Buggage, E Cunningham, M Goldbaum, B Katz, and D Guyer Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial Br J Ophthalmol, December 1, 2008; 92(12): 1606 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lange, Y. Yafai, A. Reichenbach, P. Wiedemann, and W. Eichler Regulation of Pigment Epithelium-Derived Factor Production and Release by Retinal Glial (Muller) Cells under Hypoxia Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5161 - 5167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Franco, D. C. Fernandez, P. H. Sande, M. I. Keller Sarmiento, M. Chianelli, D. A. Saenz, and R. E. Rosenstein Effect of Bacterial Lipopolysaccharide on Ischemic Damage in the Rat Retina Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4604 - 4612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Q. Yu, M. Zhang, K. I. Matis, C. Kim, and M. I. Rosenblatt Vascular Endothelial Growth Factor Mediates Corneal Nerve Repair Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3870 - 3878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Salom, M. Diaz-Llopis, S. Garcia-Delpech, P. Udaondo, M. Sancho-Tello, and F. J. Romero Aqueous Humor Levels of Vascular Endothelial Growth Factor in Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3499 - 3502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kong, H. A. Mintz-Hittner, R. L. Penland, F. L. Kretzer, and P. Chevez-Barrios Intravitreous Bevacizumab as Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study Arch Ophthalmol, August 1, 2008; 126(8): 1161 - 1163. [Full Text] [PDF]
|
|
|
|
|
|
P C. Issa, R P Finger, F G Holz, and H P N Scholl Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia Br J Ophthalmol, July 1, 2008; 92(7): 941 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, M. G. Mameza, Y. S. Lee, C. I. Eseonu, C.-R. Yu, J. J. Kang Derwent, and C. E. Egwuagu Suppressors of Cytokine-Signaling Proteins Induce Insulin Resistance in the Retina and Promote Survival of Retinal Cells Diabetes, June 1, 2008; 57(6): 1651 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Marko and D. H. Damon VEGF promotes vascular sympathetic innervation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2646 - H2652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Taoufik, E. Petit, D. Divoux, V. Tseveleki, M. Mengozzi, M. L. Roberts, S. Valable, P. Ghezzi, J. Quackenbush, M. Brines, et al. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury PNAS, April 22, 2008; 105(16): 6185 - 6190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes Diabetes, April 1, 2008; 57(4): 889 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Bryan, T. E. Walshe, D. C. Mitchell, J. S. Havumaki, M. Saint-Geniez, A. S. Maharaj, A. E. Maldonado, and P. A. D'Amore Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation Mol. Biol. Cell, March 1, 2008; 19(3): 994 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Im and A. Kazlauskas Src Family Kinases Promote Vessel Stability by Antagonizing the Rho/ROCK Pathway J. Biol. Chem., October 5, 2007; 282(40): 29122 - 29129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. D'Amore Vascular Endothelial Cell Growth Factor-A: Not Just for Endothelial Cells Anymore Am. J. Pathol., July 1, 2007; 171(1): 14 - 18. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
